Investors
The Malta Hip
Inspired by the ankle joint, the MaltaHip is a revolutionary total hip replacement designed to mimic natural joint motion while improving longevity and reducing wear. Its unique 4-part design allows movement in three directions, enhancing range of motion and significantly lowering dislocation risk.
Developed with proven biomaterials and tested in accredited laboratories, MaltaHip demonstrates exceptional wear resistance—offering a longer-lasting solution compared to conventional implants. This breakthrough aims to transform outcomes for patients and healthcare providers alike.
A WHOLE life HIP REPLACEMENT
Younger, active patients can have a whole life surgery
Stability & WIDE RANGE OF MOVEMENT
Patients can resume active lifestyles without dislocation risk
IMPROVED HOSPITAL EFFICIENCY
Reduction in procedures leading to both cost savings and improvement in sustainability
Market Potential
TAM: $7.8b
Annually 2.6m procedures worldwide
Ageing population
Obesity driving osteoarthritis
SAM: $2.35b
783k procedures annually US*
USA: less burdensome regulatory route for metal/polymer hip devices
SOM: $42m
14k procedures annually*
Underserved populations:
Younger, active patients 45-60
Including women child-bearing age
Validation and Recognition
The project is an industrial and academic collaboration between Garland Surgical and the University of Leeds. It contributes to a £500K research project that will enable us to reach some key product development and regulatory milestones on our MaltaHip commercialisation journey. The 15 month-long undertaking will also involve collaboration with the inventing team at the University of Malta, and the Advanced Manufacturing Research Centre at the University of Sheffield.
timeline
Team Expertise
Invest
Our current seed round is a combination of £1.5m grant funding and a £2m equity raise. Over the last 12 months we have £2.5m of the total amount committed. Minimum ticket size is £25k and we have £2m EIS advanced assurance from HMRC available for UK Investors.
£3.5m Target
The round closes on 31st March so please get in contact with us to have the opportunity to invest in this exciting venture!
Get in touch to discuss investment opportunities
We are happy to discuss investment opportunities with potential investors.
Details about latest investment opportunities can be found by clicking the get in touch button below.